{
  "issues": [
    "Renal tool flagged missing BMI and lab timestamps, limiting precise contrast dose calculation and renal risk assessment.",
    "Agent 2 selected a CT Pulmonary Angiography protocol (CT_CHEST_ANGIO_PULMONARY_EMBOLISM) that is not optimized for evaluation of a traumatic thoracic aortic injury.",
    "Severe hypotension (MAP 49.3 mmHg, SBP 78 mmHg) markedly increases the risk of contrast‑induced nephropathy and may predispose to hemodynamic decompensation during contrast administration, yet the recommendations focus mainly on renal hydration without addressing blood pressure stabilization.",
    "No explicit plan for contrast dose reduction, use of low‑ or iso‑osmolar agents, or split‑bolus technique to minimize nephrotoxic load.",
    "Lack of alternative imaging strategies (e.g., dedicated CT aortography, transesophageal echocardiography, MRI) despite the high‑risk hemodynamic profile.",
    "Hydration recommendation is vague; no specific fluid type, rate, or timing relative to contrast is provided."
  ],
  "recommendations": [
    "Select a dedicated CT Aortography protocol (e.g., 'CT Thoracic Aorta Angiography') rather than a pulmonary embolism CTA; this protocol provides optimal arterial phase timing for aortic injury assessment.",
    "Obtain the patient’s weight and calculate BMI to enable weight‑based contrast dosing; aim for the lowest effective iodine load (e.g., 1.5 mL/kg of low‑ or iso‑osmolar contrast, maximum 100 mL).",
    "Stabilize hemodynamics before contrast administration: initiate vasopressor support as needed to achieve MAP ≥65 mmHg, then proceed with imaging.",
    "Implement aggressive IV hydration: 1 L isotonic saline over 30 min pre‑contrast, followed by 1 L over the next 2 h post‑contrast, adjusting for cardiac status.",
    "Use low‑ or iso‑osmolar, non‑ionic contrast agents and consider a split‑bolus technique to reduce peak iodine concentration.",
    "Monitor renal function (serum creatinine, eGFR) at baseline, 24 h, and 48 h after contrast exposure; have a contingency plan for dialysis if acute kidney injury develops.",
    "Document exact timestamps for all relevant labs (creatinine, BUN, electrolytes) to improve future renal risk assessments.",
    "If MAP cannot be safely corrected, consider non‑contrast imaging alternatives: transesophageal echocardiography (TEE) for aortic injury, or MRI angiography if feasible.",
    "Include a post‑procedure hemodynamic monitoring order set: continuous arterial blood pressure, urine output, and repeat labs.",
    "Educate the care team on the specific renal safety notes from the chosen protocol, ensuring contrast‑to‑eGFR ratio remains <1.0 g/(mL·min)."
  ],
  "confidence": 0.78,
  "agent2_confidence": 0.45,
  "timestamp": "2025-08-26T10:42:27.089664Z",
  "tool_outputs": {
    "renal": {
      "tool_id": "renal_tool_v2",
      "checks": [
        {
          "id": "egfr_ckd_epi",
          "units": "ml/min/1.73m2",
          "timestamp": "2025-08-26T10:42:23.853828Z",
          "priority": "critical",
          "value": 135.1,
          "status": "pass",
          "reason": "Low renal risk for contrast."
        },
        {
          "id": "creatinine_mg_dl",
          "units": "mg/dL",
          "timestamp": "2025-08-26T10:42:23.853836Z",
          "priority": "critical",
          "value": 0.5,
          "status": "pass",
          "reason": "Creatinine within normal range."
        },
        {
          "id": "bun_creatinine_ratio",
          "timestamp": "2025-08-26T10:42:23.853842Z",
          "priority": "important",
          "value": 16.0,
          "status": "pass",
          "reason": "BUN/Cr ratio normal."
        },
        {
          "id": "potassium_mmol_l",
          "units": "mEq/L",
          "timestamp": "2025-08-26T10:42:23.853851Z",
          "priority": "important",
          "value": 3.6,
          "status": "pass",
          "reason": "Potassium normal."
        }
      ],
      "summary": {
        "overall": "pass",
        "reasons": [
          "Missing BMI or creatinine.",
          "No lab timestamps provided."
        ],
        "confidence": 0.92
      },
      "metadata": {
        "version": "2.0.0",
        "run_ts": "2025-08-26T10:42:23.853870Z"
      }
    }
  },
  "llm_raw": "{\n  \"issues\": [\n    \"Renal tool flagged missing BMI and lab timestamps, limiting precise contrast dose calculation and renal risk assessment.\",\n    \"Agent 2 selected a CT Pulmonary Angiography protocol (CT_CHEST_ANGIO_PULMONARY_EMBOLISM) that is not optimized for evaluation of a traumatic thoracic aortic injury.\",\n    \"Severe hypotension (MAP 49.3 mmHg, SBP 78 mmHg) markedly increases the risk of contrast‑induced nephropathy and may predispose to hemodynamic decompensation during contrast administration, yet the recommendations focus mainly on renal hydration without addressing blood pressure stabilization.\",\n    \"No explicit plan for contrast dose reduction, use of low‑ or iso‑osmolar agents, or split‑bolus technique to minimize nephrotoxic load.\",\n    \"Lack of alternative imaging strategies (e.g., dedicated CT aortography, transesophageal echocardiography, MRI) despite the high‑risk hemodynamic profile.\",\n    \"Hydration recommendation is vague; no specific fluid type, rate, or timing relative to contrast is provided.\"\n  ],\n  \"recommendations\": [\n    \"Select a dedicated CT Aortography protocol (e.g., 'CT Thoracic Aorta Angiography') rather than a pulmonary embolism CTA; this protocol provides optimal arterial phase timing for aortic injury assessment.\",\n    \"Obtain the patient’s weight and calculate BMI to enable weight‑based contrast dosing; aim for the lowest effective iodine load (e.g., 1.5 mL/kg of low‑ or iso‑osmolar contrast, maximum 100 mL).\",\n    \"Stabilize hemodynamics before contrast administration: initiate vasopressor support as needed to achieve MAP ≥65 mmHg, then proceed with imaging.\",\n    \"Implement aggressive IV hydration: 1 L isotonic saline over 30 min pre‑contrast, followed by 1 L over the next 2 h post‑contrast, adjusting for cardiac status.\",\n    \"Use low‑ or iso‑osmolar, non‑ionic contrast agents and consider a split‑bolus technique to reduce peak iodine concentration.\",\n    \"Monitor renal function (serum creatinine, eGFR) at baseline, 24 h, and 48 h after contrast exposure; have a contingency plan for dialysis if acute kidney injury develops.\",\n    \"Document exact timestamps for all relevant labs (creatinine, BUN, electrolytes) to improve future renal risk assessments.\",\n    \"If MAP cannot be safely corrected, consider non‑contrast imaging alternatives: transesophageal echocardiography (TEE) for aortic injury, or MRI angiography if feasible.\",\n    \"Include a post‑procedure hemodynamic monitoring order set: continuous arterial blood pressure, urine output, and repeat labs.\",\n    \"Educate the care team on the specific renal safety notes from the chosen protocol, ensuring contrast‑to‑eGFR ratio remains <1.0 g/(mL·min).\"\n  ],\n  \"confidence\": 0.88\n}",
  "hallucination_analysis": {
    "statement_assessments": [
      {
        "text": "Renal tool flagged missing BMI and lab timestamps, limiting precise contrast dose calculation and renal risk assessment.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Agent 2 selected a CT Pulmonary Angiography protocol (CT_CHEST_ANGIO_PULMONARY_EMBOLISM) that is not optimized for evaluation of a traumatic thoracic aortic injury.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Severe hypotension (MAP 49.3 mmHg, SBP 78 mmHg) markedly increases the risk of contrast‑induced nephropathy and may predispose to hemodynamic decompensation during contrast administration, yet the recommendations focus mainly on renal hydration without addressing blood pressure stabilization.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact '49.3'"
      },
      {
        "text": "No explicit plan for contrast dose reduction, use of low‑ or iso‑osmolar agents, or split‑bolus technique to minimize nephrotoxic load.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Lack of alternative imaging strategies (e.g., dedicated CT aortography, transesophageal echocardiography, MRI) despite the high‑risk hemodynamic profile.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Hydration recommendation is vague; no specific fluid type, rate, or timing relative to contrast is provided.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Select a dedicated CT Aortography protocol (e.g., 'CT Thoracic Aorta Angiography') rather than a pulmonary embolism CTA; this protocol provides optimal arterial phase timing for aortic injury assessment.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Obtain the patient’s weight and calculate BMI to enable weight‑based contrast dosing; aim for the lowest effective iodine load (e.g., 1.5 mL/kg of low‑ or iso‑osmolar contrast, maximum 100 mL).",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Stabilize hemodynamics before contrast administration: initiate vasopressor support as needed to achieve MAP ≥65 mmHg, then proceed with imaging.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Implement aggressive IV hydration: 1 L isotonic saline over 30 min pre‑contrast, followed by 1 L over the next 2 h post‑contrast, adjusting for cardiac status.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Use low‑ or iso‑osmolar, non‑ionic contrast agents and consider a split‑bolus technique to reduce peak iodine concentration.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "Monitor renal function (serum creatinine, eGFR) at baseline, 24 h, and 48 h after contrast exposure; have a contingency plan for dialysis if acute kidney injury develops.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Document exact timestamps for all relevant labs (creatinine, BUN, electrolytes) to improve future renal risk assessments.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "If MAP cannot be safely corrected, consider non‑contrast imaging alternatives: transesophageal echocardiography (TEE) for aortic injury, or MRI angiography if feasible.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Include a post‑procedure hemodynamic monitoring order set: continuous arterial blood pressure, urine output, and repeat labs.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "hemodynamic instability supported by MAP 49.3"
      },
      {
        "text": "Educate the care team on the specific renal safety notes from the chosen protocol, ensuring contrast‑to‑eGFR ratio remains <1.0 g/(mL·min).",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      }
    ],
    "counts": {
      "supported": 15,
      "inferred": 0,
      "domain_safe": 0,
      "unverified": 1,
      "contradicted": 0
    },
    "hallucination_score": 0.031,
    "recommendation": {
      "force_revision": false,
      "confidence_reduction": 0.1
    },
    "knowledge_base_summary": {
      "numbers": {
        "subject_id": 10014729.0,
        "hadm_id": 28889419.0,
        "stay_id": 33558396.0,
        "age": 21.0,
        "hospital_expire_flag": 0.0,
        "los_hospital_days": 2.47,
        "los_icu_days": 2.47,
        "creatinine_mg_dl": 0.5,
        "bun_mg_dl": 8.0,
        "glucose_mg_dl": 76.0,
        "hemoglobin_g_dl": 10.3,
        "hematocrit_pct": 29.9,
        "platelet_count": 229.0,
        "wbc_count": 6.9,
        "sodium_meq_l": 137.0,
        "potassium_mmol_l": 3.6,
        "chloride_meq_l": 97.0,
        "bicarbonate_meq_l": 25.0,
        "egfr_ckd_epi": 135.1,
        "ckd_stage": 1.0,
        "bun_creatinine_ratio": 16.0,
        "heart_rate_bpm": 107.0,
        "systolic_bp_mmhg": 78.0,
        "diastolic_bp_mmhg": 35.0,
        "map_mmhg": 49.3,
        "pulse_pressure_mmhg": 43.0,
        "temperature_f": 99.1,
        "spo2_pct": 98.0,
        "respiratory_rate": 18.0,
        "data_completeness_pct": 0.95
      },
      "raw_strings_sample": [
        "135.1",
        "33558396",
        "creatinine within normal range.",
        "43.0",
        "0.95",
        "49.3",
        "stage 1 (normal)",
        "bun/cr ratio normal.",
        "injury to thoracic aorta",
        "229.0"
      ]
    }
  },
  "feedback": {
    "issues": [
      "Renal tool flagged missing BMI and lab timestamps, limiting precise contrast dose calculation and renal risk assessment.",
      "Agent 2 selected a CT Pulmonary Angiography protocol (CT_CHEST_ANGIO_PULMONARY_EMBOLISM) that is not optimized for evaluation of a traumatic thoracic aortic injury.",
      "Severe hypotension (MAP 49.3 mmHg, SBP 78 mmHg) markedly increases the risk of contrast‑induced nephropathy and may predispose to hemodynamic decompensation during contrast administration, yet the recommendations focus mainly on renal hydration without addressing blood pressure stabilization.",
      "No explicit plan for contrast dose reduction, use of low‑ or iso‑osmolar agents, or split‑bolus technique to minimize nephrotoxic load.",
      "Lack of alternative imaging strategies (e.g., dedicated CT aortography, transesophageal echocardiography, MRI) despite the high‑risk hemodynamic profile.",
      "Hydration recommendation is vague; no specific fluid type, rate, or timing relative to contrast is provided."
    ],
    "recommendations": [
      "Select a dedicated CT Aortography protocol (e.g., 'CT Thoracic Aorta Angiography') rather than a pulmonary embolism CTA; this protocol provides optimal arterial phase timing for aortic injury assessment.",
      "Obtain the patient’s weight and calculate BMI to enable weight‑based contrast dosing; aim for the lowest effective iodine load (e.g., 1.5 mL/kg of low‑ or iso‑osmolar contrast, maximum 100 mL).",
      "Stabilize hemodynamics before contrast administration: initiate vasopressor support as needed to achieve MAP ≥65 mmHg, then proceed with imaging.",
      "Implement aggressive IV hydration: 1 L isotonic saline over 30 min pre‑contrast, followed by 1 L over the next 2 h post‑contrast, adjusting for cardiac status.",
      "Use low‑ or iso‑osmolar, non‑ionic contrast agents and consider a split‑bolus technique to reduce peak iodine concentration.",
      "Monitor renal function (serum creatinine, eGFR) at baseline, 24 h, and 48 h after contrast exposure; have a contingency plan for dialysis if acute kidney injury develops.",
      "Document exact timestamps for all relevant labs (creatinine, BUN, electrolytes) to improve future renal risk assessments.",
      "If MAP cannot be safely corrected, consider non‑contrast imaging alternatives: transesophageal echocardiography (TEE) for aortic injury, or MRI angiography if feasible.",
      "Include a post‑procedure hemodynamic monitoring order set: continuous arterial blood pressure, urine output, and repeat labs.",
      "Educate the care team on the specific renal safety notes from the chosen protocol, ensuring contrast‑to‑eGFR ratio remains <1.0 g/(mL·min)."
    ],
    "confidence": 0.78
  }
}